Krka Logo

Krka

An international generic pharmaceutical company developing human and animal health products.

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto

Description

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-05-19 08:30
Pravice delničarjev
Slovene 339.5 KB
2023-05-19 08:30
Politika prejemkov organov vodenja in nadzora
Slovene 311.2 KB
2023-05-19 08:30
Poročilo o prejemkih članov uprave in nadzornega sveta za leto 2022
Slovene 661.2 KB
2023-05-19 08:30
Obrazložitev predlogov sklepov
Slovene 454.1 KB
2023-05-19 08:30
Objava sklica 29. skupščine delničarjev
Slovene 1.2 KB
2023-05-19 08:30
Unaudited Interim Report of the Krka Group and Krka, d. d., Novo mesto for the …
English 1.5 MB
2023-05-19 08:30
Press release
English 189.4 KB
2023-05-19 08:30
Unaudited Interim Report of the Krka Group and the Krka, d. d., Novo mesto for …
English 1.1 KB
2023-05-19 08:30
Nerevidirano poročilo o poslovanju skupine Krka in družbe Krka, d. d., Novo mes…
Slovene 1.3 MB
2023-05-19 08:30
Sporočilo za javnost
Slovene 156.4 KB
2023-05-19 08:30
Nerevidirano poročilo o poslovanju skupine Krka in družbe Krka, d. d., Novo mes…
Slovene 1.1 KB
2023-05-18 08:24
Proxy statement
English 243.0 KB
2023-05-18 08:24
Registration form
English 377.4 KB
2023-05-18 08:24
Shareholders rights
English 456.8 KB
2023-05-18 08:24
Remuneration Policy for Management and Supervisory Bodies
English 332.3 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Krka

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.